Updated
IncyteINCY · Healthcare
$119.65+1.39%
Market cap$24.4B
IndustryBiotechnology
Incyte (INCY) Superinvestor holders
21 of the superinvestors we track hold Incyte (INCY) in their latest 13F filings, $4.0B in total.
Summary
The largest holder is Dodge & Cox, with $1.4B, 0.7% of the portfolio.
In their latest quarter: 2 opened a new position, 9 added, 8 trimmed.
Who holds it
Each investor's latest 13F filing, largest stake first. What a 13F shows.
| Investor | Last change | Shares | Value | % of portfolio | Filed for |
|---|---|---|---|---|---|
| Dodge & Cox | Trimmed | 11,957,326 | $1.4B | 0.7% | Q2 2026 |
| Cliff Asness AQR Capital Management |
Trimmed | 5,320,901 | $603M | 0.2% | Q2 2026 |
| Josef Lakonishok LSV Asset Management |
Trimmed | 3,881,403 | $471M | 0.9% | Q3 2026 |
| Jim Simons Renaissance Technologies |
Trimmed | 3,512,132 | $398M | 0.5% | Q2 2026 |
| Arrowstreet Capital | Trimmed | 2,744,958 | $311M | 0.1% | Q2 2026 |
| Two Sigma Two Sigma Investments |
Added | 2,003,559 | $227M | 0.2% | Q2 2026 |
| Acadian Acadian Asset Management |
Added | 1,769,818 | $215M | 0.2% | Q3 2026 |
| Paul Marshall Marshall Wace |
Added | 1,310,154 | $149M | 0.1% | Q2 2026 |
| Man Group Man Group plc |
Added | 952,941 | $108M | 0.2% | Q2 2026 |
| Joel Greenblatt Gotham Asset Management |
Added | 719,545 | $82M | 0.2% | Q2 2026 |
| Jeremy Grantham GMO |
Trimmed | 318,584 | $36M | 0.1% | Q2 2026 |
| Ensign Peak Ensign Peak Advisors |
Added | 269,956 | $31M | 0.1% | Q2 2026 |
| Ray Dalio Bridgewater Associates |
Added | 168,253 | $19M | 0.1% | Q2 2026 |
| Ken Fisher Fisher Investments |
Added | 145,442 | $18M | 0.0% | Q3 2026 |
| Alan Howard Brevan Howard |
Trimmed | 45,270 | $5M | 0.1% | Q2 2026 |
| Neil Hennessy Hennessy Advisors |
Held | 25,200 | $3M | 0.1% | Q3 2026 |
| Ken Tropin Graham Capital Management |
New position | 15,632 | $2M | 0.1% | Q2 2026 |
| Paul Tudor Jones Tudor Investment Corp |
Added | 10,828 | $1M | 0.0% | Q2 2026 |
| Brandon Haley Holocene Advisors |
Held | 7,662 | $868,564 | 0.0% | Q2 2026 |
| David Shaw D. E. Shaw & Co. |
New position | 4,016 | $455,254 | 0.0% | Q2 2026 |
| Alger Fred Alger Management |
Trimmed | 1,795 | $203,481 | 0.0% | Q2 2026 |
Holders by quarter
| Quarter | Superinvestors holding it |
|---|---|
| Q2 2026 | 21 |
| Q1 2026 | 20 |
| Q4 2025 | 20 |
| Q3 2025 | 21 |
| Q2 2025 | 20 |
| Q1 2025 | 20 |
| Q4 2024 | 22 |
| Q3 2024 | 20 |
Questions about Incyte
Which superinvestors own Incyte?
21 of the superinvestors we track hold Incyte (INCY) in their latest 13F filings, $4.0B in total. Dodge & Cox, Cliff Asness, Josef Lakonishok, Jim Simons, Arrowstreet Capital, Two Sigma.
Who is the largest superinvestor holder of INCY?
The largest holder is Dodge & Cox, with $1.4B, 0.7% of the portfolio.
From Incyte's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.